Aspira Women's Health receives Nasdaq delisting notice for failure to meet equity minimum

Aspira Women's Health Inc.

Received written notice on April 15, 2025 that Nasdaq Hearings Panel determined to delist shares due to non-compliance with Listing Rule 5550(b)(1).
Company failed to maintain minimum $2.5 million in stockholders' equity for continued listing on Nasdaq Capital Market.
Trading suspension on Nasdaq effective at open of trading on April 17, 2025.
Common stock expected to begin trading on OTC Markets under symbol AWH following suspension.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.